DexCom, Inc. DXCM is scheduled to release third-quarter 2024 results on Oct. 24, after the closing bell. In the last reported ...

DexCom, Inc. DXCM is scheduled to release ... DXCM’s continued focus on introducing new sensors like G6 and G7 in international markets and expanding coverage for its sensors is supporting ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor ... FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does ...

The introduction of sensors like G6 and G7 in international markets also fueled revenue growth. Dexcom anticipates strong growth from its recent product launches and international expansions ...

Analyst Patrick Wood from Morgan Stanley maintained a Hold rating on Dexcom (DXCM – Research Report) and keeping the price target at ...

Lastly, consider the Dexcom G6 continuous glucose monitor, a revolutionary device for people with diabetes ... Now, once a sensor is inserted into the skin, it automatically monitors glucose ...

DexCom, Inc. DXCM reported third-quarter 2024 ... The broader S&P 500 index has moved up 21.6% in the same period. Sensor and other revenues (96% of total revenues) increased 9% on a year-over ...